CTSB and pancreatitis: Investigations in mouse models carrying trypsinogen mutations with blocked trypsinogen autoactivation but preserved or even enhanced CTSB-driven activation showed no correlation between disease severity and intrapancreatic trypsin levels in caerulein pancreatitis.